0001527710-23-000003.txt : 20231204 0001527710-23-000003.hdr.sgml : 20231204 20231204171210 ACCESSION NUMBER: 0001527710-23-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tursi James Patrick CENTRAL INDEX KEY: 0001527710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 231464261 MAIL ADDRESS: STREET 1: 106 ASHLEY COURT CITY: MOORESTOWN STATE: NJ ZIP: 08057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-12-01 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001527710 Tursi James Patrick C/O NEUROBO PHARMACEUTICALS, INC. 545 CONCORD AVENUE, SUITE 210 CAMBRIDGE MA 02138 1 0 0 0 0 Common Stock 2023-12-01 4 A 0 25000 0 A 25000 D Common Stock 2023-12-01 4 A 0 7157 0 A 32157 D Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan. 50% of the RSUs immediately vested on the grant date, and the remainder will vest in two equal installments on each subsequent anniversary of the grant date, subject to continuing service. Vests on the earlier of December 1, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service. /s/ Phillip D. Torrence, by Power of Attorney 2023-12-04